Study to Access Efficacy of Ivermectin Against Covid-19

July 21, 2020

Clínica Universidad de Navarra and the Barcelona Institute for Global Health (ISGlobal), a centre supported by the "la Caixa" Foundation, have launched a clinical trial to investigate the efficacy of ivermectin against COVID-19. The aim of the study, carried out in collaboration with Idifarma, is to determine whether administration of ivermectin is associated with a shorter viral clearance time.

Ivermectin was recently shown to inhibit the replication of SARS-CoV-2 in vitro at very high doses, but this effect has not yet been studied in vivo. The new study will investigate this question in a randomised trial with twenty-four patients with mild disease and no risk factors.

 

Read full article
 

Share on Facebook
Share on Twitter
Please reload

Recent Posts
Please reload

Archive
Please reload

© 2020.  American Consortium for Small Ruminant Parasite Control (ACSRPC).  Created with Wix.com. ..